Navigation Links
Tumor suppressor pulls double shift as reprogramming watchdog
Date:8/9/2009

till they eventually give rise to the roughly 200 cell types that make up our body and generally lack the ability to revert back to a less specialized stage.

Although differentiation is generally irreversible, scientists have developed several methods to overcome the cells' reluctance to be reprogrammed. The most widely used technology involves the forced expression of four transcription factorsOct4, Sox2, Klf4, and c-Mycin fully committed adult cells.

"Unfortunately, Klf4 and c-Myc are oncogenes and adding them carries the risk of inducing cancer," says Belmonte. Yet, despite the extra push provided by those powerful oncogenes, only a tiny fraction transmogrifies into iPSCs that look and act like embryonic stem cells, leading Belmonte to question whether what they were doing to get the cells to reprogram induced a response that stopped the cells from growing?

A conversation with his next-door neighbor, cancer expert Wahl provided some fresh ideas that could be tested in the lab. "Normally, cells don't reprogram so there must be a mechanism in place that prevents it," says Wahl. "We knew that c-Myc and some of the other genes that are required for reprogramming activate the tumor suppressor p53 and we wondered whether it had any part in it."

And sure enough, experiments by postdoctoral researchers and co-first authors Teruhisa Kawamura, Ph.D., and Jotaro Suzuki, Ph.D., revealed that adding the reprogramming factors c-Myc and Klf4, alone or in various combinations activated the p53 pathway. As a first-responder, the tumor suppressor p53 is called to action when cells experience stressful conditions. Depending on the situation, p53 then turns on genes that halt cell division to allow time for repairs or, when all rescue attempts prove futile, order the cell to stop dividing forever or to commit suicide.

In cells genetically engineered to lack p53, reprogramming efficiency was at least 10-fold increased compared to contro
'/>"/>

Contact: Gina Kirchweger
kirchweger@salk.edu
858-453-4100 x1340
Salk Institute
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. La Jolla Institute discovers novel tumor suppressor
2. Nanoparticle-delivered suicide genes slowed ovarian tumor growth
3. Scientists discover gene mutation responsible for hereditary neuroendocrine tumor
4. Tumor suppressor gene in flies may provide insights for human brain tumors
5. Cancer-causing protein can also help fight the tumors it causes
6. Potential for non-invasive brain tumor treatment
7. Protein linked to change in tissue that surround and support breast tumors
8. Tumor growth and chemo response may be predicted by mathematical model
9. Computer model predicts brain tumor growth and evolution
10. From cars to cancer: UH professor employs auto industry tools for tumor therapy
11. Hebrew University researchers neutralize tumor growth in embryonic stem cell therapy
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Tumor suppressor pulls double shift as reprogramming watchdog
(Date:5/6/2015)... 6, 2015 LifeBEAM, a developer of bio-sensing ... announced today that they will expand their partnership in ... bio-sensing cycling helmet and the first joint project between ... colors in order to give cyclists more style choices ... LifeBEAM and Lazer announced their plan to release a ...
(Date:5/5/2015)... May 5, 2015, NXT-ID, Inc. (NASDAQ: NXTD ... on the growing mobile commerce market, reminds investors and media ... Officer, is presenting  at CARTES SECURE CONNEXIONS AMERICA 2015, held ... The three-day conference is organized into a ... in is themed Global Fraud: Where is the Trust ...
(Date:4/27/2015)...  For more than four decades, AUVSI,s Unmanned ... premier worldwide event for the unmanned land, sea, and ... for any local, national, or trade news organization interested ... and current applications of unmanned technologies. The conference will ... billion industry, and how it will soon impact the ...
Breaking Biology News(10 mins):LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 4UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 5
... the German physician Paul Ehrlich coined the term Zuberkugel, or ... Magic bullets, also called silver bullets, because of the ... remain the goal of drug development efforts today. A ... currently working on a magic bullet for cancer, a disease ...
... developing a new hydrosurgery system to help physicians better manage excessive bleeding ... Oberdier, a Ph.D. candidate in ... help surgeons readily clear excess blood and control bleeding during critical stages ... "We are creating a ...
... assistant professor of engineering and science education Julie ... Faculty Early Career Development (CAREER) Award to study ... enter engineering fields. Trenor will use the ... capital to better understand undergraduate engineering students, academic ...
Cached Biology News:A golden bullet for cancer 2A golden bullet for cancer 3A golden bullet for cancer 4A golden bullet for cancer 5Clemson researcher receives grant to study engineering enrollment of women, minorities 2
(Date:5/6/2015)... , May 6, 2015 ... anzukündigen, dass das Unternehmen einen mehrjährigen Vertrag ... dem das Unternehmen exklusiv für den Vertrieb ... 2 S) konventionellen und organischen Wein- und ... tritt ab sofort in Kraft. ...
(Date:5/6/2015)... , May 6, 2015 Bone Biologics, Corp., ("Bone ... with Hankey Capital, LLC ("Hankey Capital") of Los ... protein for use in bone regenerative medicine using the patented ... with patients undergoing spinal fusion. Michael ... with the completion of this round of funding which will ...
(Date:5/6/2015)... and ANN ARBOR, Mich. , May ... Robert Penny , CEO will give the keynote ... Repositories (ISBER) 2015 Annual Meeting in Phoenix, ... Dr. Penny,s talk, entitled "Personalized Medicine: The Odyssey" will focus ... over the past ten years in shaping our personalized ...
(Date:5/6/2015)... SHENZHEN, China , May 6, 2015 ... http://www.beikebiotech.com ) – Beike Biotechnology, the world,s ... ,high-dose, umbilical cord derived mesenchymal stem cell packets containing ... pack. This new product could significantly reduce the ... and therapies, especially in the case of degenerative ...
Breaking Biology Technology:Renaissance Yeast Inc. ernennt Quercus Europe, S.L. zum exklusiven Fachhändler für Schwefelwasserstoff-vermeidende Wein- und Mosthefen in Spanien 2Bone Biologics Corp Completes Financing With Hankey Capital, LLC 2Bone Biologics Corp Completes Financing With Hankey Capital, LLC 3Paradigm CEO Dr. Robert Penny Presents Keynote Address at 2015 ISBER Conference 2Paradigm CEO Dr. Robert Penny Presents Keynote Address at 2015 ISBER Conference 3Beike Biotechnology Produces High-dose Adult Stem Cell Packets for Degenerative Conditions 2
... and Product Offering , ... Rochester, ... a leading innovator in advanced cardiac safety biomakers and automated ... revenue growth as its quarter over quarter revenues have grown ...
... and OPAXIO Approval and CommercializationSEATTLE, Feb. 20 Cell ... that it exercised its option to sell its 50% ... Pharmaceuticals, Inc. (Spectrum) for $18 million. CTI and Spectrum ... and commercialize Zevalin. At that time CTI contributed all ...
... ABBOTT PARK, Ill., Feb. 20 The board of ... company,s quarterly common dividend 11 percent to 40 cents per ... increased its dividend payout and the 341st consecutive quarterly dividend ... dividend is payable May 15, 2009, to shareholders of record ...
Cached Biology Technology:iCardiac Reports Significant Revenue Growth and Profitability 2iCardiac Reports Significant Revenue Growth and Profitability 3Cell Therapeutics Exercises Its Option to Sell Interest in Zevalin Joint Venture to Spectrum Pharmaceuticals for $18 Million 2Cell Therapeutics Exercises Its Option to Sell Interest in Zevalin Joint Venture to Spectrum Pharmaceuticals for $18 Million 3Cell Therapeutics Exercises Its Option to Sell Interest in Zevalin Joint Venture to Spectrum Pharmaceuticals for $18 Million 4
Contained in EZ-Tn5™ Kits and are available separately for sequencing of an insertion site....
Immunogen: Tissue / cell preparation. (Murine EHS laminin preparation) Storage: -20 C, Avoid Freeze/Thaw Cycles...
Request Info...
Human Carnosine Dipeptidase 1 Affinity Purified PAb...
Biology Products: